Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J Immunol. 1996 Feb 01; 156(3):1095-100.
View in:
PubMed
subject areas
Animals
Antibodies, Neoplasm
Base Sequence
Cytokines
Female
Graft Rejection
Hindlimb
Immunophenotyping
Interferon-gamma
Interleukin-12
Lymph Nodes
Mast-Cell Sarcoma
Mice
Mice, Inbred C57BL
Mice, Inbred DBA
Molecular Sequence Data
Neoplasm Transplantation
Recombinant Proteins
Tumor Cells, Cultured
authors with profiles
Thomas F. Gajewski